- The FDA issued warning letters to BIOTA Biosciences, LLC and Homero Corp DBA Natures CBD Oil Distribution for selling unapproved products containing cannabidiol (CBD) in violation of the Federal Food,
Virginia Governor Signs Bill Defining Industrial Hemp Extract as Food
Posted on
- On April 6, Virginia Governor Ralph Northam signed a bill that defines “industrial hemp extract” as a food. Senate Bill 918, which was introduced by David W. Marsden (D-Fairfax),
…
Continue Reading Virginia Governor Signs Bill Defining Industrial Hemp Extract as Food
FDA Provides Congressionally-Mandated Cannabidiol (CBD) Report but Reveals Little Progress
Posted on
- We have discussed a public hearing that FDA held on May 31, 2019 to obtain scientific data and safety information on the wide array of FDA-regulated products already on the
Proposed Class Action Urges Court Not to Dismiss Suit Against Florida CBD Manufacturer (subscription to Law360 required)
Posted on
- A proposed class of consumers is urging a Massachusetts federal judge not to dismiss its suit against a Florida CBD supplement manufacturer over the potency of its products. By way
Supplemental New Drug Application Submitted for FDA-Approved CBD Drug Epidiolex
Posted on
- As previously reported in this blog, the 2018 Farm Bill removed hemp – defined as Cannabis sativa L. with less than 0.3% THC on a dry weight basis –
…
Continue Reading Supplemental New Drug Application Submitted for FDA-Approved CBD Drug Epidiolex
Bipartisan Group of Representatives Introduces Bill that Would Give FDA Authority to Regulate CBD as a Dietary Supplement (Law360 subscription required)
Posted on
- On January 13, 2020, the House Agriculture Committee Chairman Collin Peterson (D- Minn.) introduced H.R. 5587, which would include hemp derived CBD in the definition of dietary supplements under
Putative Class Action Alleges Company’s CBD Products for Humans and Animals Violate Federal Law (subscription to Law360 required)
Posted on
Proposed Class Action Alleges Company’s CBD Products Violate Federal Law (subscription to Law360 required)
Posted on
11th Circuit Rules for Plaintiffs in Class Action Lawsuit Based on Economic Loss From Purchase of ‘Worthless’ Supplements Containing DMBA – an Impermissible NDI
Posted on
- We previously reported on a flurry of FDA enforcement actions in 2015 based on adulteration per se, which followed years of relative inaction in the dietary supplement marketing arena outside
CBD Update: FDA Takes More Aggressive Enforcement Action in Warning Letters to Companies
Posted on
- On November 25, 2019, FDA issued warning letters to 15 companies for illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C